Elisa M Vuorinen Selected Research

DNA (Deoxyribonucleic Acid)

1/2022	Novel ZNF414 activity characterized by integrative analysis of ChIP-exo, ATAC-seq and RNA-seq data.
5/2015	Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisa M Vuorinen Research Topics

Disease

9	Neoplasms (Cancer) 04/2024 - 05/2015
1	Breast Neoplasms (Breast Cancer) 04/2024
1	Oligodendroglioma 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2015
2	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2018
2	alpha KaryopherinsIBA 01/2019 - 01/2018
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 04/2024
1	CytokinesIBA 04/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2023
1	Small Interfering RNA (siRNA)IBA 01/2018

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 04/2024 - 11/2023